| [1] |
Xiaowei Chi, Qi Li, Yi Zhong, Tong Gong, Chuxiao Yi, Liangren Zhang, Zhenming Liu.
Discovery of potential xanthine oxidase inhibitors based on virtual screening
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 626-635.
|
| [2] |
Hui Wu, Gang Ning, Bonan Li, Xing Zhou.
Effect of Nrf2 on the testicular microenvironment and its research progress in male diseases
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 513-526.
|
| [3] |
Wenbo Wang, Mengke Wang, Zonghai Hu, Jie Xiong, Yuan Liu.
Cidofovir inhibits human adenovirus type 55 infection in vitro
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(6): 473-477.
|
| [4] |
Jinghua Su, Chao Zhang, Lei Sun, Shuangcheng Ma, Yiwen Xing.
Establishment of a variety identification system for Fritillaria Thunbergii Bulbus and Fritillaria Cirrhosae Bulbus based on nucleosides and nucleobases with multivariate analysis and pattern recognition
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 406-416.
|
| [5] |
Xinfeng Zou, Haihua Guo, Liangjun Deng, Yuting Yang, Zhengqiang Yuan, Wen Tan.
A study of irritable bowel syndrome model construction based on combined factor stimulation
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 180-189.
|
| [6] |
Ciyan Peng, Jing Chen, Sini Li, Jianhe Li, Liubao Peng.
Evidence-based pharmacoeconomic evaluation of palbociclib in combination with letrozole versus docetaxel in combination with epirubicin in the first-line treatment of advanced breast cancer with epirubicin
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 214-222.
|
| [7] |
Wuyinxiao Zheng, Haiping Li, Laichun Luo, Chunling Hu, Pengtao You.
PI3K/AKT/mTOR pathway inhibition and miR-210-mediated suppression of Atg7 promote autophagy in TOPC-induced apoptosis of H1975 cells
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 881-892.
|
| [8] |
Yanqing Zhou, Yonghong Liu, Yanting Li, Yanru Tao, Jin Li, Xinhui Jiang.
Determination of chlorogenic acid and rutin in extractive solution of ficus virens leaves by HPLC-PDA
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 45-51.
|
| [9] |
Xiaoqing Chen, Bo Peng, Hongmei Jiang, Changxu Zhang, Haiyan Li, Ziyin Li.
Salvianolic acid B alleviates oxidative stress in non-alcoholic fatty liver disease by mediating the SIRT3/FOXO1 signaling pathway
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 698-710.
|
| [10] |
Wenbin Liu, Dong Liu, Xue Wang, Zhaoliang Yang, Yun He, Yang Yang.
Oseltamivir decorated gold nanorods for visible rapid detection of influenza virus
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(7): 491-498.
|
| [11] |
Wenjun Xie, Haoran Xiao, Xintong Wang, Zongze Huang, Xiling Bian, Kewei Wang, Qi Sun.
Sonogashira coupling reaction in the synthesis of novel positive allosteric modulators of α7 nicotinic acetylcholine receptors
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(5): 374-381.
|
| [12] |
Chanjuan Zhang, Likun Hu, He Zhang, Xinyi Qi, Jian Huang, Dong Liu.
2-Hydroxycircumdatin C inhibits LPS-induced BV2 cells inflammatory response via down-regulation of TLR4-mediated NF-κB/MAPK and JAK2/STAT3 pathways
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(4): 239-249.
|
| [13] |
Yumei Lou, Xiaoying Ge, Zhelan Zheng, Linyuan Xie, Jiangfang Lian, Wenjun Shen, Kenan Lou, Wanying Hu, Dexing Hu.
The effect of spironolactone on the levels of GATA4 protein and hypoxia inducible factor-1α in patients receiving coronary stent implantation
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(2): 134-141.
|
| [14] |
Yingqiu Tu, Tiantian Xu, Hongwei Peng, Zhangren Chen, Xin Lai, Qing Wan, Decheng Pan, Jie Zhang.
The analysis and improvements of pharmacist-led parenteral nutrition prescription review strategies
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(2): 142-152.
|
| [15] |
Xintong Zhao, Yuhua Hu, Tong Qin, Tianlei Li, Wenxuan Zhang, Song Wu.
The synthesis and antibacterial activity evaluation of oxazolidinone-deferasirox conjugates
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(12): 946-952.
|